Research Options:

Week of Expected Pricing Pending
Company Name BIOPHARMX CORP
Proposed Ticker N/A
CUSIP 09072X101
Business Description A specialty pharmaceutical company focused on utilizing our proprietary drug delivery technologies to develop and commercialize novel prescription and over-the-counter, or OTC, products that address large markets in women's health and dermatology.
Lead Underwriter CRT Capital Group LLC
Co-Managers Feltl and Company, Inc ,Newbridge Securities Corporation
Initial Shares 33,33,334
Revised Initial Shares N/A
Initial Price $2.75-$3.25
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.